CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.75 and has seen 0.95 million shares traded in the recent trading session. The company, currently
CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.79 and has seen 1.21 million shares traded in the last trading session. The company, currently
During the last session, CRISPR Therapeutics AG (NASDAQ:CRSP)’s traded shares were 1.73 million, with the beta value of the company hitting 1.78. At the end
In the last trading session, 1.42 million shares of the CRISPR Therapeutics AG (NASDAQ:CRSP) were traded, and its beta was 1.78. Most recently the company’s
CRISPR Therapeutics AG (NASDAQ:CRSP)’s traded shares stood at 1.2 million during the last session, with the company’s beta value hitting 1.78. At the close of
CRISPR Therapeutics AG (NASDAQ: CRSP) expects to submit an application for gene therapy approval by the end of the year. This medicine already earned good
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
